Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-17T19:07:48.016Z Has data issue: false hasContentIssue false
  • English
  • Français

LONGTERM OFF-LABEL USE OF SSRI IN TREATMENT OF EARLY EJACULATION: TWO CASES REPORT

Published online by Cambridge University Press:  19 July 2023

E. Becirovic  and
A. Becirovic
E. Becirovic*
Affiliation:
Klinika za psihijatriju
A. Becirovic
Affiliation:
UKC Tuzla, Tuzla, Bosnia and Herzegovina
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Early ejaculation is besides erectile dysfunction the most common exual dysfunction amog males. It can create suffering and inflence relationships. Selective serotonin reuptake inhibitors has known side effect and sometimes are used as treatment for early ejaculation.

Objectives

To present successful off-label treatment of early ejaculation.

Methods

Case report. Two cases.

Results

Two male patientes with early ejaculation problems that influenced their romatic and sexual life. Older one of them has devorced because of that. Younger has never had romantic or sexual relationship for the same reason. Prescribing SSRI make their love life more productiv. Older one married for the second time and has functional and stabile relationship. Younger one established several romantic and sexualn relatinship and currently is in a stabile romantic relationship.

Conclusions

Longterm use of low doses SSRI can be very beneficial in treatment of early ejaculation.

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S1096 - S1097
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.